Source: Neuropsychiatric disease and treatment. Unidade: FM
Subjects: ESQUIZOFRENIA, TOLERÂNCIA, PACIENTES, COMPOSTOS HETEROCÍCLICOS, PACIENTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GATTAZ, Wagner Farid et al. Treatment of patients with recently exacerbated schizophrenia with paliperidone palmitate: a pilot study of efficacy and tolerability. Neuropsychiatric disease and treatment, v. 16, p. 2063-2072, 2020Tradução . . Disponível em: https://doi.org/10.2147/NDT.S233537. Acesso em: 16 ago. 2024.APA
Gattaz, W. F., Saracco-Alvarez, R., Daltio, C. S., Bilt, M. T. V. de, Ortegon, J. J., Villasenor-Bayardo, S. J., et al. (2020). Treatment of patients with recently exacerbated schizophrenia with paliperidone palmitate: a pilot study of efficacy and tolerability. Neuropsychiatric disease and treatment, 16, 2063-2072. doi:10.2147/NDT.S233537NLM
Gattaz WF, Saracco-Alvarez R, Daltio CS, Bilt MTV de, Ortegon JJ, Villasenor-Bayardo SJ, Louza M, Elkis H, Soares B, Jaramillo PC. Treatment of patients with recently exacerbated schizophrenia with paliperidone palmitate: a pilot study of efficacy and tolerability [Internet]. Neuropsychiatric disease and treatment. 2020 ; 16 2063-2072.[citado 2024 ago. 16 ] Available from: https://doi.org/10.2147/NDT.S233537Vancouver
Gattaz WF, Saracco-Alvarez R, Daltio CS, Bilt MTV de, Ortegon JJ, Villasenor-Bayardo SJ, Louza M, Elkis H, Soares B, Jaramillo PC. Treatment of patients with recently exacerbated schizophrenia with paliperidone palmitate: a pilot study of efficacy and tolerability [Internet]. Neuropsychiatric disease and treatment. 2020 ; 16 2063-2072.[citado 2024 ago. 16 ] Available from: https://doi.org/10.2147/NDT.S233537